BioEnterprise Announces New Executive Briefing Series
CLEVELAND – Dec. 6, 2017 – Eighty experts from across the country gathered at the Global Center for Health Innovation (Global Center) yesterday to tackle the challenges and potential benefits of leveraging data to improve healthcare. Led by BioEnterprise, “Healthcare Transformation: The Opportunities and Challenges in Leveraging Data,” is the first in a series of executive briefings to be held at the Global Center.
This first briefing, presented by PNC Bank, attracted participation from MasterCard, GE Healthcare, Nokia, Cleveland Clinic, Siemens, Blue Cross/Blue Shield Ventures, RRE Ventures, Nokia Growth Partners, IBM Watson Health, IBM Ventures, and select CEOs from high growth technology companies including Xealth, Health Reveal, OnShift, ExactCare Pharmacy and Redox.
“These briefings, targeted at c-suite leaders from industry, venture capital and private equity, and their portfolio company executives, provide a unique opportunity for access and open discussion around the opportunities and challenges in achieving healthcare transformation,” said Aram Nerpouni, president and CEO, BioEnterprise.
Focused on trends, challenges and implementation of artificial intelligence (AI) and machine learning solutions in healthcare, industry experts discussed how big data, AI, enhanced reality and other disruptive technologies engage patients and clinicians in ways that will take healthcare to new levels.
According to Accenture’s “Artificial Intelligence: Healthcare’s New Nervous System” report, spending on healthcare AI is expected to reach $6.6 billion by 2021, representing greater than 40 percent annual growth.
“These briefings help enhance thought leadership around critical issues impacting the biomedical industry and have the power to bring the brightest minds together to accomplish great things in Cleveland,” said Paul Clark, PNC regional president of Cleveland.
The second BioEnterprise Executive Briefing will be held in spring 2018; the event topic and exact dates are to be announced.
This executive session is a prequel to the forthcoming second annual Medical Capital Innovation Competition, also to focus on big data, AI, Enhanced Reality and other disruptive technologies.
About PNC Bank
PNC Bank, National Association, is a member of The PNC Financial Services Group, Inc. (NYSE: PNC). PNC is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com.
BioEnterprise is a business formation, recruitment, and acceleration effort designed to grow the Northeast Ohio healthcare industry. Located in Cleveland, at the Global Center for Health Innovation and in University Circle, BioEnterprise provides management counsel and support services to health IT, medical device, and biopharmaceutical companies. In addition, BioEnterprise convenes and leads strategy for industry-building initiatives such as The Medical Capital, HIT in the CLE, and the Global Center for Health Innovation. BioEnterprise founders are Case Western Reserve University, Cleveland Clinic, and University Hospitals. Additional technology partners include the NASA Glenn Research Center, Cleveland State University and BioOhio. Since 2002, BioEnterprise and its partners have created, recruited and accelerated more than 350 health IT, medical device, and biopharmaceutical companies, and have helped these companies raise more than $2 billion in new funding. To learn more: BioEnterprise.com.